#Japan #Tokyo #Bracco Japan #Kohei Endo #Imaging Diagnostics

Bracco Japan Welcomes New Leadership

Bracco Japan Co., Ltd., headquartered at 1-13-21 Minami-Ikebukuro, Toshima-ku, Tokyo, has announced the appointment of Kohei Endo as the new CEO effective March 31, 2026. The transition marks a pivotal moment for the company, emphasizing its commitment to enhancing early disease detection through advancements in imaging diagnostics.

A Strategic Career Path

Kohei Endo started his career as a marketing consultant for healthcare companies after graduating from university. He further bolstered his expertise by obtaining an MBA from Duke University in the United States. This background has equipped him with a robust understanding of both the healthcare and business sectors.

Following his studies, Endo joined a prominent medical device manufacturer where he played a crucial role in restructuring underperforming business units. His leadership skills and deep market insights culminated in his recent position as the head of the Japan branch at Integra LifeSciences, where he also managed operations across Hong Kong, Taiwan, and Mongolia.

These experiences place him in a prime position to lead Bracco Japan into its next phase, focusing on critical innovations in medical imaging technology.

Transitional Leadership

The previous CEO, Tetsuya Sakamoto, will step down from his role as director on the same date. His tenure was marked by several milestones, and his departure opens the door for a fresh perspective and innovative leadership under Endo.

Vision for the Future

Under Kohei Endo’s guidance, Bracco Japan is poised to advance the company’s mission to contribute to early disease detection through imaging diagnostics. The commitment is to introduce new products and innovative practices that enhance healthcare delivery in Japan, ensuring that medical professionals have access to the best quality imaging solutions available. This strategic direction showcases Bracco Japan’s promise to remain at the forefront of the healthcare sector.

Bracco Japan is a part of the Bracco Group, a renowned multinational conglomerate with a legacy that dates back to 1927. With a mission to provide high-quality pharmaceutical solutions for imaging diagnostics, Bracco Japan supplies medical professionals across Japan, impacting countless patients' diagnostic and treatment journeys every day.

About Bracco Group

Bracco Group, headquartered in Milan, Italy, operates across various healthcare sectors with divisions such as Bracco Imaging for diagnostic imaging and Bracco Medical Technologies focusing on cardiology. With approximately 4,000 employees, the Bracco Group maintains a global presence in over 100 countries, boasting an annual consolidated revenue exceeding 2 billion euros. The company continually strives for excellence in healthcare innovation and patient care, underpinning its commitment to improving health outcomes worldwide.

For more information about Bracco Japan and its contributions to healthcare, visit Bracco's website.